Executive record
Sam Martin
Sam Martin is in the CFO seat at Celldex Therapeutics, Inc. until a disclosed change takes effect (effective March 31, 2027).
2 verified records · 1 company · current seat on the record: Celldex Therapeutics, Inc.
Career line from the records
2Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-07-15DepartureCelldex Therapeutics, Inc.current seat
Celldex Therapeutics, Inc. discloses CFO departure: Sam MartinNamed as the outgoing officer
effective March 31, 2027 · 8-K filed July 15, 2026 · sec.gov, Item 5.02
2026-02-2510-K signatureCelldex Therapeutics, Inc.current seat
Signed the annual report as Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)
10-K filed February 25, 2026 · sec.gov
Companies
1This page lists only verified filing records that name Sam Martin, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.